TGFB1 and systemic sclerosis: SSc fibroblasts have the characteristics of healthy fibroblasts activated by TGF-β [17], implying TGF-β as a main mediator of fibrosis in SSc, which is further supported by the fact that elevated levels of TGF-β have been described in patients with SSc [18].